Mutation screening of germline TP53 mutations in high-risk Chinese breast cancer patients. Kwong A, Shin VY, Ho CYS, Au CH, et al. BMC Cancer 2020;20:1053.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Kwong A, Shin VY, Ho CYS, Au CH, et al. Mutation screening of germline TP53 mutations in high-risk Chinese breast cancer patients. BMC Cancer 2020;20:1053.
PMID: 33138793